

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.18543678 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.88481542 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.88481542 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.26908221 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.26908221 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.26908221 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.26908221 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.26908221 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.26908221 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12579948 |
| 11 | microglial cell activation (GO:0001774) | 5.00794623 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.95626313 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.89518437 |
| 14 | cellular extravasation (GO:0045123) | 4.72085881 |
| 15 | activated T cell proliferation (GO:0050798) | 4.63173284 |
| 16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.61733720 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.43785223 |
| 18 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.42529745 |
| 19 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.42529745 |
| 20 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.42529745 |
| 21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.35752769 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.21113625 |
| 23 | T cell migration (GO:0072678) | 4.10141931 |
| 24 | germ cell migration (GO:0008354) | 4.08846671 |
| 25 | positive T cell selection (GO:0043368) | 4.07113844 |
| 26 | B cell receptor signaling pathway (GO:0050853) | 4.04261974 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.97983405 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.95233340 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91799065 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 3.70979679 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67570838 |
| 32 | response to host (GO:0075136) | 3.65115116 |
| 33 | response to host defenses (GO:0052200) | 3.65115116 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65115116 |
| 35 | negative T cell selection (GO:0043383) | 3.64663502 |
| 36 | response to host immune response (GO:0052572) | 3.63570501 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.63570501 |
| 38 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.63450346 |
| 39 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.63450346 |
| 40 | RNA destabilization (GO:0050779) | 3.61980309 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.59827158 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.59805297 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.53842541 |
| 44 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.51844390 |
| 45 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.51844390 |
| 46 | negative regulation of granulocyte differentiation (GO:0030853) | 3.51789291 |
| 47 | leukocyte aggregation (GO:0070486) | 3.49312931 |
| 48 | B cell homeostasis (GO:0001782) | 3.47104240 |
| 49 | B cell proliferation (GO:0042100) | 3.45651093 |
| 50 | tolerance induction (GO:0002507) | 3.45444068 |
| 51 | response to cholesterol (GO:0070723) | 3.44214097 |
| 52 | positive regulation of Rap GTPase activity (GO:0032854) | 3.43549951 |
| 53 | I-kappaB phosphorylation (GO:0007252) | 3.42803902 |
| 54 | negative thymic T cell selection (GO:0045060) | 3.34095213 |
| 55 | germinal center formation (GO:0002467) | 3.33958863 |
| 56 | T cell selection (GO:0045058) | 3.33405151 |
| 57 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.32694844 |
| 58 | natural killer cell differentiation (GO:0001779) | 3.32208259 |
| 59 | thymic T cell selection (GO:0045061) | 3.31174388 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.28453209 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 3.23427948 |
| 62 | positive regulation of chemokine secretion (GO:0090197) | 3.23366671 |
| 63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.19659934 |
| 64 | positive regulation of mRNA catabolic process (GO:0061014) | 3.19232294 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.17998663 |
| 66 | interferon-gamma production (GO:0032609) | 3.15010157 |
| 67 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.12847719 |
| 68 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11835327 |
| 69 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11334232 |
| 70 | mature B cell differentiation (GO:0002335) | 3.09758172 |
| 71 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.08911657 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.08699860 |
| 73 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.06639729 |
| 74 | response to interleukin-15 (GO:0070672) | 3.04330105 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03698590 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03698590 |
| 77 | macrophage activation (GO:0042116) | 3.02837055 |
| 78 | G-protein coupled receptor internalization (GO:0002031) | 3.02360472 |
| 79 | response to sterol (GO:0036314) | 3.01346679 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00456396 |
| 81 | dendritic cell migration (GO:0036336) | 2.99719510 |
| 82 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.99625182 |
| 83 | T cell homeostasis (GO:0043029) | 2.99183136 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.98411626 |
| 85 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.98411626 |
| 86 | cellular response to ethanol (GO:0071361) | 2.98339090 |
| 87 | detection of other organism (GO:0098543) | 2.98256128 |
| 88 | response to type I interferon (GO:0034340) | 2.97482285 |
| 89 | cellular response to type I interferon (GO:0071357) | 2.97475421 |
| 90 | type I interferon signaling pathway (GO:0060337) | 2.97475421 |
| 91 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96842130 |
| 92 | regulation of mRNA catabolic process (GO:0061013) | 2.94828503 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.93444057 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93232439 |
| 95 | negative regulation of adaptive immune response (GO:0002820) | 2.93078231 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.91831645 |
| 97 | negative regulation of B cell proliferation (GO:0030889) | 2.91477786 |
| 98 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.90748772 |
| 99 | lymphocyte homeostasis (GO:0002260) | 2.90530595 |
| 100 | regulation of Rap GTPase activity (GO:0032317) | 2.89364998 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.86189237 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.84234254 |
| 103 | regulation of germinal center formation (GO:0002634) | 2.83694877 |
| 104 | alpha-beta T cell differentiation (GO:0046632) | 2.82689713 |
| 105 | regulation of T cell tolerance induction (GO:0002664) | 2.81483714 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80243057 |
| 107 | * T cell receptor signaling pathway (GO:0050852) | 2.79372017 |
| 108 | detection of bacterium (GO:0016045) | 2.79259896 |
| 109 | regulation of alpha-beta T cell activation (GO:0046634) | 2.79117759 |
| 110 | monocyte differentiation (GO:0030224) | 2.78927773 |
| 111 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78074763 |
| 112 | histone H3-K4 trimethylation (GO:0080182) | 2.77921334 |
| 113 | negative regulation of interleukin-12 production (GO:0032695) | 2.76801842 |
| 114 | immunoglobulin mediated immune response (GO:0016064) | 2.75381041 |
| 115 | negative regulation of bone resorption (GO:0045779) | 2.75333064 |
| 116 | adaptation of signaling pathway (GO:0023058) | 2.75251624 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 2.74757433 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74463012 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 2.74322011 |
| 120 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.73745946 |
| 121 | regulation of granulocyte differentiation (GO:0030852) | 2.72865127 |
| 122 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72152347 |
| 123 | mast cell activation (GO:0045576) | 2.71996599 |
| 124 | hepatocyte apoptotic process (GO:0097284) | 2.71309594 |
| 125 | cytidine deamination (GO:0009972) | 2.70014744 |
| 126 | cytidine metabolic process (GO:0046087) | 2.70014744 |
| 127 | cytidine catabolic process (GO:0006216) | 2.70014744 |
| 128 | dendritic cell chemotaxis (GO:0002407) | 2.69598874 |
| 129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69532385 |
| 130 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.67780537 |
| 131 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.67780537 |
| 132 | negative regulation of phagocytosis (GO:0050765) | 2.67486733 |
| 133 | neutrophil mediated immunity (GO:0002446) | 2.67368969 |
| 134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.67061232 |
| 135 | detection of external biotic stimulus (GO:0098581) | 2.66287754 |
| 136 | Peyers patch development (GO:0048541) | 2.65970350 |
| 137 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.65970350 |
| 138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.65191682 |
| 139 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.65115613 |
| 140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63697128 |
| 141 | neutrophil activation (GO:0042119) | 2.63321429 |
| 142 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.60950058 |
| 143 | alpha-beta T cell activation (GO:0046631) | 2.60627106 |
| 144 | leukocyte cell-cell adhesion (GO:0007159) | 2.60012029 |
| 145 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.59708662 |
| 146 | T cell costimulation (GO:0031295) | 2.59300108 |
| 147 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.58596010 |
| 148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58169835 |
| 149 | positive regulation of granulocyte differentiation (GO:0030854) | 2.58046228 |
| 150 | cellular defense response (GO:0006968) | 2.57660549 |
| 151 | mononuclear cell proliferation (GO:0032943) | 2.57468371 |
| 152 | regulation of B cell proliferation (GO:0030888) | 2.53432856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.98584260 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.88700996 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.44539911 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.39089058 |
| 5 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.32268115 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30592465 |
| 7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.25157600 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16440327 |
| 9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15660948 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08634211 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01490724 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.92989472 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.87879384 |
| 14 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.77975948 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.74530496 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73544466 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68110436 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.40727567 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.38712089 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29918636 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29648647 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27756923 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18825848 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11429721 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06054409 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.05630273 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05316635 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.02273605 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.96916743 |
| 30 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.94718647 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93187213 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91107563 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90429857 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84175066 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83628345 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.79870307 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79642299 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74057554 |
| 39 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68907196 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67303890 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63754258 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.59420136 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56427614 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55086314 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49365468 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48185367 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48179429 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45315343 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44415365 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41687242 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36761658 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34715057 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26100499 |
| 54 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25866512 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25122968 |
| 56 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24026998 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22644735 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22366695 |
| 59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22168209 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20418495 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18992180 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17289406 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16690291 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15741339 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14722007 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11818022 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11107788 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11080134 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10718847 |
| 70 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09058548 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08919894 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08859834 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06617370 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05901274 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05425649 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05047989 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03998194 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02795747 |
| 79 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01909932 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00707465 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99619284 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99452788 |
| 83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99325460 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98678278 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98249616 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98029671 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97779358 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95647086 |
| 89 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.94294066 |
| 90 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93789903 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.93731943 |
| 92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92864884 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92402932 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.92119260 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92098543 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91497730 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91187045 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90774530 |
| 99 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89265943 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89079576 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88507749 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87042323 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86574115 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85178181 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84601325 |
| 106 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84561563 |
| 107 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84326394 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82184689 |
| 109 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82052422 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81674919 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81174242 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80613386 |
| 113 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80465902 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79937900 |
| 115 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.79937900 |
| 116 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79430088 |
| 117 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.78852504 |
| 118 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78777341 |
| 119 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77731194 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77315855 |
| 121 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76762022 |
| 122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76721166 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76613973 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76550739 |
| 125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.75561130 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74318199 |
| 127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73443110 |
| 128 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.72408657 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.72210418 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.71617627 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71367187 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69813046 |
| 133 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.69512537 |
| 134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.68785705 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 0.68496807 |
| 136 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66994614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.93665480 |
| 2 | MP0005671_abnormal_response_to | 3.90332207 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.17068686 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.99312102 |
| 5 | MP0001800_abnormal_humoral_immune | 2.99053255 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.86223894 |
| 7 | MP0003303_peritoneal_inflammation | 2.83565039 |
| 8 | MP0006082_CNS_inflammation | 2.83324794 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.70631528 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.70432304 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.66857029 |
| 12 | MP0001790_abnormal_immune_system | 2.61620951 |
| 13 | MP0005387_immune_system_phenotype | 2.61620951 |
| 14 | MP0002723_abnormal_immune_serum | 2.54255939 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.52304103 |
| 16 | MP0002419_abnormal_innate_immunity | 2.49826190 |
| 17 | MP0002009_preneoplasia | 2.49398778 |
| 18 | MP0001819_abnormal_immune_cell | 2.47817796 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.47622994 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.46647893 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.43736421 |
| 22 | MP0000685_abnormal_immune_system | 2.35661898 |
| 23 | MP0003436_decreased_susceptibility_to | 2.31922173 |
| 24 | MP0001853_heart_inflammation | 2.30815140 |
| 25 | MP0004381_abnormal_hair_follicle | 2.27170336 |
| 26 | * MP0002398_abnormal_bone_marrow | 2.24169032 |
| 27 | MP0001851_eye_inflammation | 2.23216563 |
| 28 | * MP0000716_abnormal_immune_system | 2.08850309 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.96860799 |
| 30 | MP0004947_skin_inflammation | 1.96634039 |
| 31 | MP0009278_abnormal_bone_marrow | 1.94557105 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.93918743 |
| 33 | MP0005025_abnormal_response_to | 1.93214255 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.86513331 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.83687781 |
| 36 | * MP0000703_abnormal_thymus_morphology | 1.82626050 |
| 37 | MP0004510_myositis | 1.81749599 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.81465272 |
| 39 | MP0002722_abnormal_immune_system | 1.79577283 |
| 40 | MP0002405_respiratory_system_inflammati | 1.70896244 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.68991780 |
| 42 | MP0002933_joint_inflammation | 1.68539204 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.67958711 |
| 44 | MP0003045_fibrosis | 1.64741572 |
| 45 | * MP0002429_abnormal_blood_cell | 1.62582890 |
| 46 | MP0003828_pulmonary_edema | 1.60377060 |
| 47 | MP0008260_abnormal_autophagy | 1.58070249 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.49687241 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.49246268 |
| 50 | MP0002928_abnormal_bile_duct | 1.48005908 |
| 51 | MP0002006_tumorigenesis | 1.44626891 |
| 52 | MP0003075_altered_response_to | 1.44511203 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.42631802 |
| 54 | MP0001873_stomach_inflammation | 1.40492348 |
| 55 | MP0009785_altered_susceptibility_to | 1.38984400 |
| 56 | MP0003252_abnormal_bile_duct | 1.38311489 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.34564281 |
| 58 | MP0009764_decreased_sensitivity_to | 1.34173767 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.33245403 |
| 60 | MP0003724_increased_susceptibility_to | 1.30065813 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.27813361 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.27813361 |
| 63 | MP0005310_abnormal_salivary_gland | 1.27633764 |
| 64 | MP0003690_abnormal_glial_cell | 1.27372646 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.26767747 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.23971820 |
| 67 | MP0005409_darkened_coat_color | 1.22334707 |
| 68 | MP0003866_abnormal_defecation | 1.22301895 |
| 69 | MP0004130_abnormal_muscle_cell | 1.18895739 |
| 70 | MP0005166_decreased_susceptibility_to | 1.17294630 |
| 71 | MP0003646_muscle_fatigue | 1.16845298 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.16534563 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.14296640 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.13997435 |
| 75 | MP0003787_abnormal_imprinting | 1.13080571 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.08245307 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.07436166 |
| 78 | MP0004185_abnormal_adipocyte_glucose | 1.07426094 |
| 79 | MP0008004_abnormal_stomach_pH | 1.05258058 |
| 80 | MP0008469_abnormal_protein_level | 1.03973528 |
| 81 | MP0005171_absent_coat_pigmentation | 1.01993800 |
| 82 | MP0004484_altered_response_of | 0.93558974 |
| 83 | MP0005164_abnormal_response_to | 0.93115887 |
| 84 | MP0000920_abnormal_myelination | 0.90231531 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.89850130 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.87112242 |
| 87 | MP0008874_decreased_physiological_sensi | 0.86793655 |
| 88 | MP0008057_abnormal_DNA_replication | 0.83209598 |
| 89 | MP0000604_amyloidosis | 0.81198444 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.79951587 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.79539607 |
| 92 | MP0005408_hypopigmentation | 0.76931538 |
| 93 | MP0003136_yellow_coat_color | 0.75817869 |
| 94 | MP0002090_abnormal_vision | 0.75697238 |
| 95 | MP0001663_abnormal_digestive_system | 0.74672482 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.74287153 |
| 97 | MP0000343_altered_response_to | 0.71198599 |
| 98 | MP0000249_abnormal_blood_vessel | 0.71157385 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.71050140 |
| 100 | MP0003448_altered_tumor_morphology | 0.66912596 |
| 101 | MP0000858_altered_metastatic_potential | 0.64172365 |
| 102 | MP0001919_abnormal_reproductive_system | 0.63884239 |
| 103 | MP0005023_abnormal_wound_healing | 0.62815469 |
| 104 | MP0003091_abnormal_cell_migration | 0.61252462 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.60929202 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.60869021 |
| 107 | MP0001915_intracranial_hemorrhage | 0.58993279 |
| 108 | MP0003795_abnormal_bone_structure | 0.58857740 |
| 109 | MP0000609_abnormal_liver_physiology | 0.57617157 |
| 110 | MP0008569_lethality_at_weaning | 0.57038599 |
| 111 | MP0004859_abnormal_synaptic_plasticity | 0.56671906 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.55926173 |
| 113 | MP0003633_abnormal_nervous_system | 0.55874063 |
| 114 | MP0010307_abnormal_tumor_latency | 0.55806667 |
| 115 | MP0005670_abnormal_white_adipose | 0.55640097 |
| 116 | MP0005390_skeleton_phenotype | 0.54350835 |
| 117 | MP0000490_abnormal_crypts_of | 0.54251891 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.53939708 |
| 119 | MP0004883_abnormal_blood_vessel | 0.53916012 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.53256252 |
| 121 | MP0004142_abnormal_muscle_tone | 0.53034942 |
| 122 | MP0004742_abnormal_vestibular_system | 0.52758262 |
| 123 | MP0009115_abnormal_fat_cell | 0.52394753 |
| 124 | MP0004043_abnormal_pH_regulation | 0.52384603 |
| 125 | MP0000371_diluted_coat_color | 0.49156549 |
| 126 | MP0009763_increased_sensitivity_to | 0.49033033 |
| 127 | MP0002095_abnormal_skin_pigmentation | 0.47914170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arterial tortuosity (HP:0005116) | 5.42157412 |
| 2 | Cerebral aneurysm (HP:0004944) | 4.88514227 |
| 3 | Vascular tortuosity (HP:0004948) | 4.69391102 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.47947371 |
| 5 | Aortic aneurysm (HP:0004942) | 4.32940688 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.03784086 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.01591105 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.90435350 |
| 9 | Optic neuritis (HP:0100653) | 3.90435350 |
| 10 | Thyroiditis (HP:0100646) | 3.78927956 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.73099068 |
| 12 | Chronic diarrhea (HP:0002028) | 3.70779550 |
| 13 | T lymphocytopenia (HP:0005403) | 3.64606757 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60713253 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60713253 |
| 16 | Recurrent viral infections (HP:0004429) | 3.59858434 |
| 17 | Orchitis (HP:0100796) | 3.53263626 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.52765536 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.43715263 |
| 20 | Disproportionate tall stature (HP:0001519) | 3.38104837 |
| 21 | Stomach cancer (HP:0012126) | 3.36723470 |
| 22 | Abnormality of the fingertips (HP:0001211) | 3.34535863 |
| 23 | Eosinophilia (HP:0001880) | 3.32614825 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.32506820 |
| 25 | Encephalitis (HP:0002383) | 3.31658332 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.24412318 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.23799365 |
| 28 | Striae distensae (HP:0001065) | 3.20471646 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.18644360 |
| 30 | Hemiplegia (HP:0002301) | 3.05957029 |
| 31 | Glomerulonephritis (HP:0000099) | 3.05437088 |
| 32 | Hematochezia (HP:0002573) | 3.01954160 |
| 33 | Recurrent skin infections (HP:0001581) | 3.00808614 |
| 34 | Retinal atrophy (HP:0001105) | 2.96988004 |
| 35 | IgM deficiency (HP:0002850) | 2.93966759 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 2.90885279 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.84561336 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.82860158 |
| 39 | Abnormality of eosinophils (HP:0001879) | 2.80072715 |
| 40 | Hemoptysis (HP:0002105) | 2.78828034 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.77335987 |
| 42 | Colitis (HP:0002583) | 2.76835211 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.76196528 |
| 44 | Cellulitis (HP:0100658) | 2.75715914 |
| 45 | Aortic dissection (HP:0002647) | 2.73545763 |
| 46 | Bicuspid aortic valve (HP:0001647) | 2.69848625 |
| 47 | Mitral valve prolapse (HP:0001634) | 2.69305838 |
| 48 | Abnormality of B cell number (HP:0010975) | 2.67295101 |
| 49 | B lymphocytopenia (HP:0010976) | 2.67295101 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.64174393 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.64174393 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.64174393 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57461198 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.55767922 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53300280 |
| 56 | Granulocytopenia (HP:0001913) | 2.52220519 |
| 57 | Meningitis (HP:0001287) | 2.51935335 |
| 58 | Ocular albinism (HP:0001107) | 2.50811445 |
| 59 | Chest pain (HP:0100749) | 2.50085759 |
| 60 | Abnormality of T cells (HP:0002843) | 2.46335472 |
| 61 | Leukocytosis (HP:0001974) | 2.45400695 |
| 62 | Urethral obstruction (HP:0000796) | 2.45065735 |
| 63 | Increased IgM level (HP:0003496) | 2.44448156 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.43958930 |
| 65 | Combined immunodeficiency (HP:0005387) | 2.42833779 |
| 66 | Lymphopenia (HP:0001888) | 2.41925015 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.41541953 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.41454027 |
| 69 | Cheilitis (HP:0100825) | 2.40545895 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.37661878 |
| 71 | Mediastinal lymphadenopathy (HP:0100721) | 2.36747032 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.31470205 |
| 73 | Chronic otitis media (HP:0000389) | 2.29851111 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.28286419 |
| 75 | Papilledema (HP:0001085) | 2.27434022 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25993643 |
| 77 | Blue irides (HP:0000635) | 2.25748896 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25670886 |
| 79 | Volvulus (HP:0002580) | 2.25663170 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.23006571 |
| 81 | Exotropia (HP:0000577) | 2.22396116 |
| 82 | Disinhibition (HP:0000734) | 2.21780818 |
| 83 | Macroorchidism (HP:0000053) | 2.21379992 |
| 84 | Pulmonary embolism (HP:0002204) | 2.19529514 |
| 85 | Viral hepatitis (HP:0006562) | 2.17439733 |
| 86 | Gingival bleeding (HP:0000225) | 2.16845373 |
| 87 | Recurrent sinusitis (HP:0011108) | 2.15517056 |
| 88 | Hypoplasia of the thymus (HP:0000778) | 2.14656382 |
| 89 | Generalized hypopigmentation of hair (HP:0011358) | 2.14126523 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10840539 |
| 91 | Verrucae (HP:0200043) | 2.10791070 |
| 92 | Papilloma (HP:0012740) | 2.10791070 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.10717825 |
| 94 | Myositis (HP:0100614) | 2.08810452 |
| 95 | Hyperventilation (HP:0002883) | 2.06421515 |
| 96 | Osteomyelitis (HP:0002754) | 2.06404067 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.06157776 |
| 98 | Vasculitis (HP:0002633) | 2.05993327 |
| 99 | Recurrent pneumonia (HP:0006532) | 2.04964311 |
| 100 | Pustule (HP:0200039) | 2.04559514 |
| 101 | Mutism (HP:0002300) | 2.04185136 |
| 102 | Obstructive lung disease (HP:0006536) | 2.02690955 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02690955 |
| 104 | Iris hypopigmentation (HP:0007730) | 2.02200412 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01972679 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01972679 |
| 107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01972679 |
| 108 | Sepsis (HP:0100806) | 2.00649431 |
| 109 | Increased IgE level (HP:0003212) | 2.00635138 |
| 110 | Subacute progressive viral hepatitis (HP:0006572) | 2.00485705 |
| 111 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.99187797 |
| 112 | Alveolar cell carcinoma (HP:0006519) | 1.95161185 |
| 113 | Persistence of primary teeth (HP:0006335) | 1.94672766 |
| 114 | Stomatitis (HP:0010280) | 1.94016659 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.93712333 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93712333 |
| 117 | Gangrene (HP:0100758) | 1.93381860 |
| 118 | Complement deficiency (HP:0004431) | 1.93028099 |
| 119 | Epistaxis (HP:0000421) | 1.90217057 |
| 120 | Prostate neoplasm (HP:0100787) | 1.90015897 |
| 121 | Joint swelling (HP:0001386) | 1.89951258 |
| 122 | Periodontitis (HP:0000704) | 1.89866671 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 1.89317775 |
| 124 | Lymphoma (HP:0002665) | 1.88464193 |
| 125 | Fatigue (HP:0012378) | 1.88352690 |
| 126 | Spondylolisthesis (HP:0003302) | 1.88064542 |
| 127 | Arnold-Chiari malformation (HP:0002308) | 1.87302294 |
| 128 | Gingivitis (HP:0000230) | 1.87289406 |
| 129 | Recurrent bronchitis (HP:0002837) | 1.86644387 |
| 130 | Urticaria (HP:0001025) | 1.85010425 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.84162330 |
| 132 | Abnormal platelet function (HP:0011869) | 1.84162330 |
| 133 | Slow saccadic eye movements (HP:0000514) | 1.82505703 |
| 134 | IgA deficiency (HP:0002720) | 1.81019464 |
| 135 | Abnormality of the intervertebral disk (HP:0005108) | 1.80835232 |
| 136 | Genetic anticipation (HP:0003743) | 1.80243401 |
| 137 | Abnormality of the peritoneum (HP:0002585) | 1.78537189 |
| 138 | Abnormality of macrophages (HP:0004311) | 1.78502841 |
| 139 | IgG deficiency (HP:0004315) | 1.78037225 |
| 140 | Chronic sinusitis (HP:0011109) | 1.77614317 |
| 141 | Arterial thrombosis (HP:0004420) | 1.77188955 |
| 142 | Anorexia (HP:0002039) | 1.75496990 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.75224885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.74093000 |
| 2 | GRK7 | 3.92069473 |
| 3 | MAP4K1 | 3.35399731 |
| 4 | ITK | 3.11644690 |
| 5 | SIK2 | 2.66126322 |
| 6 | TXK | 2.52926529 |
| 7 | CAMK1D | 2.18829664 |
| 8 | CSF1R | 2.10696230 |
| 9 | CDK12 | 2.08811874 |
| 10 | MAPK15 | 2.06447678 |
| 11 | SIK3 | 2.02918698 |
| 12 | EEF2K | 2.01822145 |
| 13 | STK10 | 2.00244385 |
| 14 | CAMK1G | 1.96273849 |
| 15 | RIPK4 | 1.92138057 |
| 16 | ADRBK2 | 1.83717338 |
| 17 | MAP3K10 | 1.82073424 |
| 18 | ACVR1B | 1.77050917 |
| 19 | MAP3K13 | 1.71881443 |
| 20 | ZAP70 | 1.71365965 |
| 21 | PRPF4B | 1.70238084 |
| 22 | TYK2 | 1.69579546 |
| 23 | JAK1 | 1.58556368 |
| 24 | HCK | 1.56106278 |
| 25 | SIK1 | 1.40569395 |
| 26 | BTK | 1.35508044 |
| 27 | SYK | 1.32567050 |
| 28 | IRAK4 | 1.26883891 |
| 29 | TEC | 1.26676256 |
| 30 | FGFR3 | 1.24497734 |
| 31 | MARK3 | 1.21929723 |
| 32 | CSK | 1.21312005 |
| 33 | NTRK2 | 1.18402781 |
| 34 | MAP3K2 | 1.17245447 |
| 35 | LCK | 1.15323320 |
| 36 | CLK1 | 1.12387835 |
| 37 | IRAK1 | 1.10993985 |
| 38 | MAPK12 | 1.08799448 |
| 39 | GRK6 | 1.08436034 |
| 40 | STK24 | 1.03947403 |
| 41 | FES | 1.01253985 |
| 42 | MAPK7 | 0.99049687 |
| 43 | PIK3CG | 0.98969237 |
| 44 | EPHB1 | 0.98864275 |
| 45 | MAP3K14 | 0.97351432 |
| 46 | JAK3 | 0.94915350 |
| 47 | RPS6KA4 | 0.89973761 |
| 48 | BMPR2 | 0.89681192 |
| 49 | PKN2 | 0.88046858 |
| 50 | TBK1 | 0.87212776 |
| 51 | PIM1 | 0.85793318 |
| 52 | MAP3K3 | 0.85395703 |
| 53 | STK39 | 0.83542236 |
| 54 | EPHA3 | 0.82572411 |
| 55 | * LYN | 0.81831102 |
| 56 | JAK2 | 0.79518302 |
| 57 | PRKCH | 0.79234296 |
| 58 | KIT | 0.78554778 |
| 59 | PTK6 | 0.78015796 |
| 60 | FGFR4 | 0.77985036 |
| 61 | CAMK4 | 0.77008426 |
| 62 | SGK3 | 0.76698663 |
| 63 | HIPK2 | 0.73077013 |
| 64 | CDK3 | 0.72347392 |
| 65 | PDGFRB | 0.72064450 |
| 66 | MAPKAPK2 | 0.72039991 |
| 67 | FGFR2 | 0.71518355 |
| 68 | IKBKE | 0.71432471 |
| 69 | MAPK13 | 0.69063211 |
| 70 | SGK223 | 0.68818983 |
| 71 | SGK494 | 0.68818983 |
| 72 | CAMKK2 | 0.68754266 |
| 73 | PTK2B | 0.68135522 |
| 74 | PRKCQ | 0.67880264 |
| 75 | ALK | 0.67399248 |
| 76 | MAP3K7 | 0.67057509 |
| 77 | CDK6 | 0.66836971 |
| 78 | ERN1 | 0.66359704 |
| 79 | BLK | 0.66314649 |
| 80 | PDK1 | 0.66160120 |
| 81 | PINK1 | 0.65444363 |
| 82 | MAPK11 | 0.64065046 |
| 83 | BRD4 | 0.63276911 |
| 84 | TYRO3 | 0.61888089 |
| 85 | MAP2K3 | 0.58263873 |
| 86 | MAPK4 | 0.57243357 |
| 87 | CCNB1 | 0.57002582 |
| 88 | NEK9 | 0.54805562 |
| 89 | IKBKB | 0.53115987 |
| 90 | YES1 | 0.52764737 |
| 91 | DMPK | 0.51996133 |
| 92 | CAMKK1 | 0.50822461 |
| 93 | RPS6KA6 | 0.50018027 |
| 94 | WNK1 | 0.49877052 |
| 95 | STK38 | 0.49315665 |
| 96 | PIK3CA | 0.49213548 |
| 97 | TNK2 | 0.47679022 |
| 98 | WNK4 | 0.47303988 |
| 99 | MAP3K1 | 0.47196150 |
| 100 | IGF1R | 0.46261690 |
| 101 | SGK2 | 0.46145444 |
| 102 | CAMK1 | 0.45836464 |
| 103 | MATK | 0.45290208 |
| 104 | FGR | 0.44700396 |
| 105 | EGFR | 0.43839748 |
| 106 | MARK2 | 0.43703178 |
| 107 | STK11 | 0.43355247 |
| 108 | CHUK | 0.43087745 |
| 109 | FYN | 0.42980556 |
| 110 | TAOK3 | 0.42617494 |
| 111 | MAP3K9 | 0.42273107 |
| 112 | IRAK2 | 0.41139942 |
| 113 | MELK | 0.41042218 |
| 114 | RPS6KC1 | 0.40710235 |
| 115 | RPS6KL1 | 0.40710235 |
| 116 | RET | 0.40254791 |
| 117 | SGK1 | 0.39598284 |
| 118 | ABL1 | 0.39467293 |
| 119 | TRPM7 | 0.38461025 |
| 120 | CDK9 | 0.37883674 |
| 121 | INSR | 0.36317720 |
| 122 | INSRR | 0.35920555 |
| 123 | TSSK6 | 0.35431970 |
| 124 | PAK4 | 0.35117079 |
| 125 | GRK5 | 0.35103415 |
| 126 | CDC42BPA | 0.34715159 |
| 127 | STK4 | 0.34521851 |
| 128 | PRKAA2 | 0.34213724 |
| 129 | FRK | 0.32946827 |
| 130 | LRRK2 | 0.31036729 |
| 131 | PRKD1 | 0.30553335 |
| 132 | TRIB3 | 0.30193793 |
| 133 | NLK | 0.29517685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.75899766 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.66436218 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61121847 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.39240359 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35771217 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29525436 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.07184427 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.06723149 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05663732 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89571740 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79500832 |
| 12 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.76767524 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75553976 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67301167 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.63818366 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63256366 |
| 17 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.60565958 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.58958967 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58419977 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54922947 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52971632 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.47484596 |
| 23 | Colorectal cancer_Homo sapiens_hsa05210 | 1.45516071 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43937181 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39379127 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37080456 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.36505261 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36160959 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33958160 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33178191 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.25821567 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.23472384 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.21694587 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.20862126 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17809131 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12020322 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11646108 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.11622492 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05006794 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03247209 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.02571850 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02110697 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01631331 |
| 44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01446606 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00717997 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99771827 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.95583167 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94155072 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93810611 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 0.92507758 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91998536 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89928417 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89142382 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.87149584 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85808877 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.85549387 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85501413 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85356707 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82647977 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82646712 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81492784 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.80907895 |
| 63 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80348546 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79952426 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79506392 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78842018 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78030585 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77914720 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77729392 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.76915276 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76864179 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76633998 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75805525 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74744513 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74544155 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73558212 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71926798 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.70198456 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69652738 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69627811 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.69206988 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69120139 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.68700567 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67335756 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67034797 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66755745 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63840350 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63593213 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63521672 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62951217 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62898735 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62535520 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.62529584 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.62337309 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.62010082 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60978507 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60577599 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.59870305 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59726952 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.59407269 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57421739 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55309278 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55209564 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54751471 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54596325 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53755530 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53155389 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52962427 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52006574 |
| 110 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51571229 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51126174 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.51002727 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49206264 |
| 114 | Morphine addiction_Homo sapiens_hsa05032 | 0.48866948 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44471905 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42871311 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42826458 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41432729 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40245157 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.39772939 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39610193 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39259531 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39252027 |

